NEVO Europe Presents RIVA Automatic IV Compounding at EAHP 2015

HAMBURG, Germany, March 19, 2015 /PRNewswire/ --

The world's leading pharmacy automation system will benefit European hospitals which will be able to provide better patient care while improving efficiency and cutting costs   

NEVO Europe, a specialist in IV compounding automation solutions, will launch its activities in Europe by presenting the RIVA automated IV compounding technology at the EAHP Congress 2015, which will take place in Hamburg, Germany March 25-27, 2015.

NEVO Europe will present RIVA, the world's only fully automated IV compounding system, at the 20th Congress of the European Association of Hospital Pharmacists (EAHP), booth #98.

Participants will have an opportunity to learn more about RIVA, which prepares IV admixtures in syringes and bags in an aseptic environment. By using RIVA, hospitals can enhance patient safety, lower cost-per-dose of medications and cut waste. 

"EAHP is a great opportunity for European pharmacists and hospital top management to obtain a first-hand impression of how to revolutionize their compounding facility by implementing RIVA, substantially improving patient safety while increasing operational efficiency," said Efi Gross, CEO of NEVO Europe.

"RIVA is a real game-changer. It has the largest installed base of fully automated IV compounding systems in North America, and I believe that the EAHP Congress, which this year is emphasizing the maxim 'patient safety first,' is an ideal event to launch our activities in Europe," he added.

RIVA is devised to accurately and safely increase efficiency for routine repetitive movements related to the compounding of many frequently prescribed non-hazardous admixtures. In a slightly different configuration, it can be optimized to handle the complicated, hazardous toxic formulations used in chemotherapy and biological drug infusion therapy.

NEVO Europe's team at EAHP will help visitors calculate and evaluate - according to their hospital's environment and needs - how RIVA can optimize compounding efficiency in their own facilities.

Since its introduction in 2008, RIVA systems globally have safely and accurately prepared more than three million medication doses, including more than 18,000 chemotherapy doses.

About NEVO Europe  

NEVO Europe is a leading provider of IV compounding automation technology and healthcare solutions to the European market.

We specialize in customized projects for hospital pharmacy automation offering safe, smart and cost-effective solutions from the highest quality international developers of medical devices.

For more information visit http://www.nevo-europe.com.

Contact:
Dana Barocas
Business Development & Marketing Manager
NEVO Europe
Tel: +44-797-827-9209
Email: office@nevo-europe.com